Literature DB >> 17387706

BH3-only proteins Bid and Bim(EL) are differentially involved in neuronal dysfunction in mouse models of Huntington's disease.

Juan M García-Martínez1, Esther Pérez-Navarro, Xavier Xifró, Josep M Canals, Miguel Díaz-Hernández, Yael Trioulier, Emmanuel Brouillet, José J Lucas, Jordi Alberch.   

Abstract

Apoptosis, a cell death mechanism regulated by Bcl-2 family members, has been proposed as one of the mechanisms leading to neuronal loss in Huntington's disease (HD). Here we examined the regulation of Bcl-2 family proteins in three different mouse models of HD with exon 1 mutant huntingtin: the R6/1, the R6/1:BDNF+/-, and the Tet/HD94 in which the huntingtin transgene is controlled by the tetracycline-inducible system. Our results disclosed an increase in the levels of the BH3-only proteins Bid and Bim(EL) in the striatum of HD mouse models that was different depending on the stage of the disease. At 16 weeks of age, Bid was similarly enhanced in the striatum of R6/1 and R6/1:BDNF+/- mice, whereas Bim(EL) protein levels were enhanced only in R6/1:BDNF+/- mice. In contrast, at later stages of the disease, both genotypes displayed increased levels of Bid and Bim(EL) proteins. Furthermore, Bax, Bak, Bad, Bcl-2, and Bcl-x(L) proteins were not modified in any of the points analyzed. We next explored the potential reversibility of this phenomenon by analyzing conditional Tet/HD94 mice. Constitutive expression of the transgene resulted in increased levels of Bid and Bim(EL) proteins, and only the Bid protein returned to wild-type levels 5 months after mutant huntingtin shutdown. In conclusion, our results show that enhanced Bid protein levels represent an early mechanism linked to the continuous expression of mutant huntingtin that, together with enhanced Bim(EL), may be a reporter of the progress and severity of neuronal dysfunction. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17387706     DOI: 10.1002/jnr.21258

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  11 in total

1.  Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicity.

Authors:  Ana Saavedra; Albert Giralt; Laura Rué; Xavier Xifró; Jian Xu; Zaira Ortega; José J Lucas; Paul J Lombroso; Jordi Alberch; Esther Pérez-Navarro
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

2.  RTP801 Is Involved in Mutant Huntingtin-Induced Cell Death.

Authors:  Núria Martín-Flores; Joan Romaní-Aumedes; Laura Rué; Mercè Canal; Phil Sanders; Marco Straccia; Nicholas D Allen; Jordi Alberch; Josep M Canals; Esther Pérez-Navarro; Cristina Malagelada
Journal:  Mol Neurobiol       Date:  2015-04-16       Impact factor: 5.590

Review 3.  The many faces of autophagy dysfunction in Huntington's disease: from mechanism to therapy.

Authors:  Constanza J Cortes; Albert R La Spada
Journal:  Drug Discov Today       Date:  2014-03-13       Impact factor: 7.851

4.  Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.

Authors:  Xiao Zhou; Gang Li; Anna Kaplan; Michael M Gaschler; Xiaoyan Zhang; Zhipeng Hou; Mali Jiang; Roseann Zott; Serge Cremers; Brent R Stockwell; Wenzhen Duan
Journal:  Hum Mol Genet       Date:  2018-05-01       Impact factor: 6.150

5.  Increased Levels of Rictor Prevent Mutant Huntingtin-Induced Neuronal Degeneration.

Authors:  Jordi Creus-Muncunill; Laura Rué; Rafael Alcalá-Vida; Raquel Badillos-Rodríguez; Joan Romaní-Aumedes; Sonia Marco; Jordi Alberch; Isabel Perez-Otaño; Cristina Malagelada; Esther Pérez-Navarro
Journal:  Mol Neurobiol       Date:  2018-02-19       Impact factor: 5.590

6.  BimEL as a possible molecular link between proteasome dysfunction and cell death induced by mutant huntingtin.

Authors:  Rebecca Leon; Nithya Bhagavatula; Onome Ulukpo; Mark McCollum; Jianning Wei
Journal:  Eur J Neurosci       Date:  2010-05-24       Impact factor: 3.386

7.  Early down-regulation of PKCδ as a pro-survival mechanism in Huntington's disease.

Authors:  Laura Rué; Rafael Alcalá-Vida; Graciela López-Soop; Jordi Creus-Muncunill; Jordi Alberch; Esther Pérez-Navarro
Journal:  Neuromolecular Med       Date:  2013-07-30       Impact factor: 3.843

Review 8.  Defining the role of the Bcl-2 family proteins in Huntington's disease.

Authors:  J Sassone; A Maraschi; F Sassone; V Silani; A Ciammola
Journal:  Cell Death Dis       Date:  2013-08-15       Impact factor: 8.469

Review 9.  From pathways to targets: understanding the mechanisms behind polyglutamine disease.

Authors:  Jonasz Jeremiasz Weber; Anna Sergeevna Sowa; Tina Binder; Jeannette Hübener
Journal:  Biomed Res Int       Date:  2014-09-21       Impact factor: 3.411

Review 10.  The Unfolded Protein Response and the Role of Protein Disulfide Isomerase in Neurodegeneration.

Authors:  Emma R Perri; Colleen J Thomas; Sonam Parakh; Damian M Spencer; Julie D Atkin
Journal:  Front Cell Dev Biol       Date:  2016-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.